Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology | Neurology | Genetic Disease | Family Medicine
 Disease Category: Bipolar Disorder
Location: United States, IL

Trial Information

Depression in Bipolar Disorder - Relapse Prevention

This study compares combination treatment with an FDA approved mood stabilizer plus an FDA approved antidepressant to treatment with the mood stabilizer alone; also gathers information about the safety, tolerability and frequency of mod changes during continuation treatment. The purpose of the study is to gather information about whether combining the mood stabilizer with the antidepressant results in fewer returns of depressive symptoms compared to treatment with the mood stabilizer alone. Study participation can last up to 62-weeks.

Patient Inclusion Criteria:

  • Male or Female aged 18-65
  • Diagnosis of Bipolar Disorder, currently experiencing a depressive episode
  • Able to understand study related documents and procedures

Patient Exclusion Criteria:

  • Alcohol or Substance abuse within the past 3 months
  • Must be medically stable
  • Previous treatment with study medication
  • Actively suicidal or requiring hospitalization
  • Fails to meet all study criterion

Michael Topel, LCPC, Coordinator
Psychiatric Medicine Associates/John Zajecka, M.D.
4711 Gold Road, Suite 1200
Skokie, IL 60076
Phone: 847-679-8000
Fax: 847-679-8002
Email: Michael_Topel@rush.edu

View Map

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.